Diagnostic yield of the Kveim test in sarcoidosis patients Kveim test

Main Article Content

Cuneyt Tetikkurt
Emre Yanardag
Muammer Bilir
Halil Yanardag
Ugur Kimyon


Kveim test, sarcoidosis, radiology, diagnosis


Background and aim: Sarcoidosis is a granulomatous disorder of unknown etiology characterized by the existence of non-caseating granulomatous inflammation. Diagnosis can be challenging due to the presence of comprehensive clinical, laboratory, and radiologic manifestations. We have evaluated the diagnostic yield of the Kveim test and compared this test with the other conventional laboratory modalities. Our aim was to reach the highest level of diagnostic confidence acknowledging the absolute uncertainty in diagnosis with the current diagnostic enterprises. Methods: Medical records of 300 sarcoidosis patients were reviewed. Patients were classified into two categories as the conventional laboratory and the Kveim test group to compare the diagnostic yield. Results: Sensitivity of the Kveim test was 76.4% while the conventional laboratory tests provided a 64% diagnostic yield.  The conventional tests had a low diagnostic rate in the early disease stages. Kveim test revealed a high yield diagnosis for all stages of sarcoidosis. Integrated assessment of the two modalities reached a 96.8% sensitivity and a 94,6% specificity. Conclusions: Conventional laboratory modalities were useful for the assessment of disease activity and identification of organ involvement. Kveim test revealed a significant diagnostic yield for all stages of sarcoidosis. The lowest output was achieved in stage IV patients due to the waning of active granulomatous inflammation.  The highest diagnostic sensitivity was obtained by an integrated analysis of the conventional laboratory and the Kveim test results for all aspects of sarcoidosis.

Abstract 242 | PDF Downloads 189


1. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10):1885-9.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-55.
3. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14(4):735-7.
4. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149-73.
5. Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19-27.
6. Govender P, Bermen JS. The Diagnosis of Sarcoidosis. Clinics in Chest Medicine. 2015;36(4):585-602.
7. Schober P, Boer C, Schwarte LA. Correlation Coefficients: Appropriate Use and Interpretation. Anesth Analg. 2018;126(5):1763-1768.
8. Siltzbach LE, Ehrlich JC. The Nickerson-Kveim reaction in sarcoidosis. Am J Med. 1954;16(6):790–803.
9. D G James, W J Williams. Kveim-Siltzbach test revisited. Sarcoidosis 1991;8(1):6-9.
10. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):36-52.
11. J R Mikhail, D N Mitchell. The Kveim test in sarcoidosis. Postgrad Med J. 1970;46(538):484-5.
12. Terčelj M, Salobir B, Rylander R. β-glucan in the lymph nodes in sarcoidosis and in Kveim-Siltzbach test reagent. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):130-5.
13. T H Hurley, J R Sullivan, J V Hurley. Reaction to Kveim test material in sarcoidosis and other diseases. Lancet. 1975;1(7905):494-6.
14. A J Karlish, E V Cox, F Hampson, E H Hemsted. The Kveim test in Crohn's disease, ulcerative colitis, and coeliac disease. Lancet. 1972;1(7747):438-9.
15. Reich JM. On the nature of sarcoidosis. Eur J Intern Med. 2012;23(2):105-9.
16. Reich JM. Anomalies in the dominant sarcoidosis paradigm justify its displacement. Immunobiology. 2017;222(4):672-5.
17. C M Bradstreet, M W Dighero, D N Mitchell. The Kveim test: analysis of results of tests using colindale (K 12) materials. Ann N Y Acad Sci.1976;278:681-6.